Inhibition of complement C1s by sutimlimab (SUT) in patients with cold agglutinin disease (CAD): results on efficacy and safety from the randomized, placebo-controlled phase 3 CADENZA study (NCT03347422)

被引:0
|
作者
Roeth, A. [1 ]
Berentsen, S. [2 ]
Barcellini, W. [3 ]
D'Sa, S. [4 ]
Jilma, B. [5 ]
Michel, M. [6 ]
Weitz, I. C. [7 ]
Yamaguchi, M. [8 ]
Nishimura, J. -i [9 ]
Vos, J. M. [10 ,11 ]
Storek, M. [12 ]
Wong, N. W. [12 ]
Patel, P. [12 ]
Jiang, X. [12 ]
Vagge, D. [13 ]
Wardecki, M. [14 ]
Shafer, F. [12 ]
Lee, M. [12 ]
Broome, C. M. [15 ]
机构
[1] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, West German Canc Ctr, Essen, Germany
[2] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[4] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England
[5] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[6] UPEC, Henri Mondor Univ Hosp, Assistance Publ Hop Paris, Creteil, France
[7] USC, Keck Sch Med, Jane Anne Nohl Div Hematol, Dept Med, Los Angeles, CA USA
[8] Ishikawa Prefectural Cent Hosp, Dept Hematol, Kanazawa, Japan
[9] Osaka Univ, Osaka, Japan
[10] Amsterdam UMC, Amsterdam, Netherlands
[11] Sanquin, Dept Hematol, Amsterdam, Netherlands
[12] Sanofi, Cambridge, England
[13] IQVIA, Bangalore, Karnataka, India
[14] Sanofi, Warsaw, Poland
[15] MedStar Georgetown Univ Hosp, Div Hematol, Washington, DC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V575
引用
收藏
页码:172 / 173
页数:2
相关论文
共 50 条
  • [1] Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422)
    Roeth, Alexander
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    Michel, Marc
    Weitz, Ilene C.
    Yamaguchi, Masaki
    Nishimura, Jun-ichi
    Vos, Josephine M., I
    Cid, Joan
    Storek, Michael
    Wong, Nancy
    Yoo, Ronnie
    Wang, Jennifer
    Vagge, Deepthi
    Wardecki, Marek
    Shafer, Frank
    Lee, Michelle
    Broome, Catherine M.
    [J]. BLOOD, 2022, 140 : 2825 - 2827
  • [2] Sustained complement C1s inhibition with sutimlimab in patients with cold agglutinin disease results in continued efficacy during part B of the randomized placebo-controlled phase 3 CADENZA study (NCT03347422)
    Roeth, Alexander
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    Michel, Marc
    Weitz, Ilene C.
    Yamaguchi, Masaki
    Nishimura, Jun-ichi
    Vos, Josephine M. I.
    Cid, Joan
    Storek, Michael
    Wong, Nancy
    Yoo, Ronnie
    Wang, Jennifer
    Vagge, Deepthi S.
    Wardecki, Marek
    Shafer, Frank
    Lee, Michelle
    Broome, Catherine M.
    [J]. IMMUNOBIOLOGY, 2023, 228 (05) : 10 - 10
  • [3] Sustained complement C1s inhibition with sutimlimab in patients with cold agglutinin disease results in continued efficacy during part B of the randomized placebo-controlled phase 3 CADENZA study (NCT03347422)
    Roeth, A.
    Berentsen, S.
    Barcellini, W.
    D'Sa, S.
    Jilma, B.
    Michel, M.
    Weitz, I. C.
    Yamaguchi, M.
    Nishimura, J., I
    Vos, J. M.
    Cid, J.
    Storek, M.
    Wong, N.
    Yoo, R.
    Wang, J.
    Vagge, D. S.
    Wardecki, M.
    Shafer, F.
    Lee, M.
    Broome, C. M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 120 - 120
  • [4] C1s-targeted inhibition of classical complement pathway by sutimlimab in cold agglutinin disease (CAD): Efficacy and safety results from the randomized, placebo (PBO)-controlled phase 3 CADENZA study
    Roth, A.
    Berentsen, S.
    Barcellini, W.
    D'Sa, S.
    Jilma, B.
    Michel, M.
    Weitz, I. C.
    Yamaguchi, M.
    Nishimura, J., I
    Vos, J. M., I
    Patel, P.
    Schaible, B.
    Jiang, X.
    Vagge, D. S.
    Wardecki, M.
    Shafer, F.
    Lee, M.
    Broome, C. M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 40 - 41
  • [5] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Lin, Stella
    Jiang, Xiaoyu
    Reuter, Caroline
    Hobbs, William
    Berentsen, Sigbjorn
    [J]. BLOOD, 2019, 134
  • [6] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2020, 105 : S38 - S38
  • [7] Sutimlimab in patients with cold agglutinin disease results of the randomized placebo-controlled phase 3 CADENZA trial
    Roeth, Alexander
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    Michel, Marc
    Weitz, Ilene C.
    Yamaguchi, Masaki
    Nishimura, Jun-ichi
    Vos, Josephine M., I
    Storek, Michael
    Wong, Nancy
    Patel, Parija
    Jiang, Xiaoyu
    Vagge, Deepthi S.
    Wardecki, Marek
    Shafer, Frank
    Lee, Michelle
    Broome, Catherine M.
    [J]. BLOOD, 2022, 140 (09) : 980 - 991
  • [8] Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    Sa, D. S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, Anderson T. H.
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 177 - 177
  • [9] Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B
    Roeth, Alexander
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    Michel, Marc
    Weitz, Ilene C.
    Yamaguchi, Masaki
    Nishimura, Jun-ichi
    Vos, Josephine M. I.
    Cid, Joan
    Storek, Michael
    Wong, Nancy
    Yoo, Ronnie
    Jayawardene, Deepthi
    Srivastava, Shruti
    Wardecki, Marek
    Shafer, Frank
    Lee, Michelle
    Broome, Catherine M.
    [J]. ECLINICALMEDICINE, 2024, 74
  • [10] Inhibition of Complement Cis By Suti limab in Patients h Cold Agglutinin Disease (CAD): Efficacy and Safety Results om the Rando ized, Placebo-Controlled Phase 3 CADENZA Study
    Roeth, Alexander
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    Michel, Marc
    Weitz, Ilene C.
    Yamaguchi, Masaki
    Nishimura, Jun-Ichi
    Vos, Josephine M. I.
    Storek, Michael
    Wong, Nancy
    Patel, Parija
    Schaible, Braydon
    Jiang, Xiaoyu
    Vagge, Deepthi
    Wardecki, Marek
    Shafer, Frank
    Lee, Michelle
    Broome, Catherine M.
    [J]. BLOOD, 2021, 138